IDS w/Melissa Bondy – Molecular & Genetic Epidemiology of Glioma

• Virtual presentation via Microsoft Teams (Click here to join the meeting) | Meeting ID: 212955863223 | Passcode: 8wDzWB
  Or call in (audio only): 302-483-7154 | Phone Conference ID: 474168961#
• Please RSVP by emailing Debra Reese. Please include your full name, email address, and institution/organization.
• This activity has been approved for AMA PRA Category 1 Credit. We will provide instructions on obtaining CME credit for attendance.

Molecular and Genetic Epidemiology of Glioma

Presentation Summary: In this virtual presentation, Dr. Melissa Bondy, PhD, Stanford University, will introduce the epidemiology of glioma and the known risk factors. She will present the results from several large multi-center studies that she has been conducting to unravel the genetic predisposition to glioma in families. She conducted whole genome sequencing in about 320 individuals with a history of familial glioma and will present the genes identified. Dr. Bondy has also created a Google Ad that targets individuals searching for information on family history of gliomas to identify more study participants. In addition, she is conducting functional genomics that verified the causative gene. Although she and her team have potentially identified causal variants in many families, the majority remain without any casual variant identified.

About the Speaker:

Dr. Melissa Bondy is the Chair of the Department of Epidemiology and Population Health, Co-Director of the Center for Population Health Sciences, and Associate Director for Population Sciences at Stanford. She is an internationally recognized cancer epidemiologist with a multi-disciplinary focus on translational research with a strong interest in health disparities. She conducts research in genetic and molecular epidemiology to assess the roles of genetic susceptibility in the etiology of cancer and outcomes, primarily in brain and breast cancer. She was President of the American College of Epidemiology, and a member of many NCI Cancer Center’s Advisory Boards.